Aflac Incorporated announced today that Aflac Japan will introduce a cancer insurance product exclusively for Japan Post Co., Ltd. and Kampo (Japan Post Insurance Co., Ltd.) on October 1, 2014.

This new cancer insurance product sold through Japan Post and Kampo will provide a lump-sum benefit for initial cancer diagnosis as well as benefits for hospital stays, outpatient visits and anti-cancer drug treatments.

Commenting on this new product introduction, Aflac Chairman and CEO Daniel P. Amos said, "During this year that marks Aflac's 40th anniversary in Japan, we are strengthening our partnership with Japan Post Group and enhancing Aflac's value proposition to potential policyholders by offering a new cancer insurance product. This product focuses on cancer-related benefits that customers of Japan Post and Kampo desire while also delivering value. We believe the introduction of this product advances our progress in gradually, but steadily increasing cancer insurance sales through postal outlets across Japan."